Method of controlling emesis caused by cisplatin in cancer chemo

Details Method of controlling emesis caused by cisplatin in cancer chemo Method of controlling emesis caused by cisplatin in cancer chemo

1983-06-27

1985-08-20

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Identification or warning feature

Taste or smell or chemical irritation to the eye, nose, or...

424131, 514619, A61K 3324, A61K 31165

Patent

active

045363862

ABSTRACT:
High dosages of metoclopramide or a pharmaceutical salt thereof is administered intravenously to human cancer patients undergoing cisplatin chemotherapy to prevent emesis.

REFERENCES:
patent: 3177252 (1965-04-01), Thomland
Kahn et al., Cancer Treatment Reports, vol. 62, No. 7, Jul. 1978, pp. 1106-1107.
Gylys, Res. Common in Chem. Path. Pharm. 23(1), pp. 62-68, (1979).

Affiliated with

Also associated with

Rating

Method of controlling emesis caused by cisplatin in cancer chemo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of controlling emesis caused by cisplatin in cancer chemo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of controlling emesis caused by cisplatin in cancer chemo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-560513